Infectious Diseases – News and Features

The $750,000+ Phase II grant will continue the design and development of accurate assays for pathogens of military importance.

First independent validation of detect-ready MRSA assay in a peer-reviewed scientific forum.

Collaboration is based on recent DKFZ discovery suggesting cervical cancer risk may be more precisely determined.

Agreement reinforces Roche’s leadership in the fight against hepatitis C.

The discovery of a hormone acting like molecular glue could hold a key to bolstering plant immune systems and understanding how plants cope with environmental stress.

28 panels for nearly 400 genes are available as screening tool to gene testing.

The high-resolution structure sheds light on how the molecule functions and could point to ways to control its activity to lock out HIV and cancer's spread.

BAC has successfully completed and delivered positive results from the initial feasibility study of its CaptureSelect® in collaboration with Genmab.

$65 million in contracts to help advance disease detection, delivery of therapies.

CEVEC Pharmaceuticals has announced that CAP cells produce high virus titers upon infection with influenza strains.